🟢 MEDPAL AI is trading 11.15% up today; catalyst remains unclear

MEDPAL AI is trading at £4.17 (+11.15%), although the catalyst remains unclear.

• No identified company-specific announcement is dated August 26, 2026; its latest RNS concerned Eli Lilly’s once-daily GLP-1 pill.
• A 238 million-share lock-up expires on August 26, 2026, but available reporting does not establish it as the cause of the gain.
• Broader markets are mixed.